Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Urolithiasis
Published in: Urolithiasis 4/2012

01-08-2012 | 11th International Urolithiasis Symposium

Selective Rac1 inhibition protects renal tubular epithelial cells from oxalate-induced NADPH oxidase-mediated oxidative cell injury

Authors: Vijayalakshmi Thamilselvan, Mani Menon, Sivagnanam Thamilselvan

Published in: Urolithiasis | Issue 4/2012

Login to get access

Abstract

Oxalate-induced oxidative cell injury is one of the major mechanisms implicated in calcium oxalate nucleation, aggregation and growth of kidney stones. We previously demonstrated that oxalate-induced NADPH oxidase-derived free radicals play a significant role in renal injury. Since NADPH oxidase activation requires several regulatory proteins, the primary goal of this study was to characterize the role of Rac GTPase in oxalate-induced NADPH oxidase-mediated oxidative injury in renal epithelial cells. Our results show that oxalate significantly increased membrane translocation of Rac1 and NADPH oxidase activity of renal epithelial cells in a time-dependent manner. We found that NSC23766, a selective inhibitor of Rac1, blocked oxalate-induced membrane translocation of Rac1 and NADPH oxidase activity. In the absence of Rac1 inhibitor, oxalate exposure significantly increased hydrogen peroxide formation and LDH release in renal epithelial cells. In contrast, Rac1 inhibitor pretreatment, significantly decreased oxalate-induced hydrogen peroxide production and LDH release. Furthermore, PKC α and δ inhibitor, oxalate exposure did not increase Rac1 protein translocation, suggesting that PKC resides upstream from Rac1 in the pathway that regulates NADPH oxidase. In conclusion, our data demonstrate for the first time that Rac1-dependent activation of NADPH oxidase might be a crucial mechanism responsible for oxalate-induced oxidative renal cell injury. These findings suggest that Rac1 signaling plays a key role in oxalate-induced renal injury, and may serve as a potential therapeutic target to prevent calcium oxalate crystal deposition in stone formers and reduce recurrence.
Literature
1.
Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR (2008) Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 19:1197–1203PubMedCrossRef
2.
Thamilselvan S, Byer KJ, Hackett RL, Khan SR (2000) Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 164:224–229PubMedCrossRef
3.
Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059–1063PubMedCrossRef
4.
Thamilselvan S, Menon M (2005) Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 96:117–126PubMedCrossRef
5.
Maroni PD, Koul S, Chandhoke PS, Meacham RB, Koul HK (2005) Oxalate toxicity in cultured mouse inner medullary collecting duct cells. J Urol 174:757–760PubMedCrossRef
6.
Scheid C, Koul H, Hill WA, Luber-Narod J, Jonassen J, Honeyman T, Kennington L, Kohli R, Hodapp J, Ayvazian P, Menon M (1996) Oxalate toxicity in LLC-PK1 cells, a line of renal epithelial cells. J Urol 155:1112–1116PubMedCrossRef
7.
Khan SR, Byer KJ, Thamilselvan S, Hackett RL, McCormack WT, Benson NA, Vaughn KL, Erdos GW (1999) Crystal–cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells. J Am Soc Nephrol 10(Suppl 14):S457–S463PubMed
8.
Wiessner JH, Hasegawa AT, Hung LY, Mandel NS (1999) Oxalate-induced exposure of phosphatidylserine on the surface of renal epithelial cells in culture. J Am Soc Nephrol 10(Suppl 14):S441–S445PubMed
9.
Jonassen JA, Cooney R, Kennington L, Gravel K, Honeyman T, Scheid CR (1999) Oxalate-induced changes in the viability and growth of human renal epithelial cells. J Am Soc Nephrol 10(Suppl 14):S446–S451PubMed
10.
Koul H, Kennington L, Nair G, Honeyman T, Menon M, Scheid C (1994) Oxalate-induced initiation of DNA synthesis in LLC-PK1 cells, a line of renal epithelial cells. Biochem Biophys Res Commun 205:1632–1637PubMedCrossRef
11.
Peixoto EB, Pessoa BS, Biswas SK, Lopes de Faria JB (2009) Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am J Nephrol 29:309–318
12.
Rashed T, Menon M, Thamilselvan S (2004) Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 24:557–568
13.
Umekawa T, Byer K, Uemura H, Khan SR (2005) Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells. Nephrol Dial Transplant 20:870–878
14.
Moriyama MT, Miyazawa K, Noda K, Oka M, Tanaka M, Suzuki K (2007) Reduction in oxalate-induced renal tubular epithelial cell injury by an extract from Quercus salicina Blume/Quercus stenophylla Makino. Urol Res 35:295–300
15.
Thamilselvan V, Menon M, Thamilselvan S (2009) Oxalate-induced activation of PKC-alpha and -delta regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cells. Am J Physiol Renal Physiol 297:F1399–F1410
16.
Yoshioka I, Tsujihata M, Akanae W, Nonomura N, Okuyama A (2011) Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys. Urology 77:1007.e9–1007.e14
17.
18.
Zuo J, Khan A, Glenton PA, Khan SR (2011) Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats. Nephrol Dial Transplant 26:1785–1796
19.
DeLeo FR, Quinn MT (1996) Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins. J Leukoc Biol 60:677–691PubMed
20.
Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245–313PubMedCrossRef
21.
Abo A, Pick E, Hall A, Totty N, Teahan CG, Segal AW (1991) Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353:668–670PubMedCrossRef
22.
Diekmann D, Abo A, Johnston C, Segal AW, Hall A (1994) Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity. Science 265:531–533PubMedCrossRef
23.
Kinsella BT, Erdman RA, Maltese WA (1991) Carboxyl-terminal isoprenylation of ras-related GTP-binding proteins encoded by rac1, rac2, and ralA. J Biol Chem 266:9786–9794PubMed
24.
Sussman MA, Welch S, Walker A, Klevitsky R, Hewett TE, Price RL, Schaefer E, Yager K (2000) Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1. J Clin Invest 105:875–886PubMedCrossRef
25.
Li C, Hu Y, Mayr M, Xu Q (1999) Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways. J Biol Chem 274:25273–25280PubMedCrossRef
26.
Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK (2002) Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91:406–413PubMedCrossRef
27.
Jones GE, Allen WE, Ridley AJ (1998) The Rho GTPases in macrophage motility and chemotaxis. Cell Adhes Commun 6:237–245PubMedCrossRef
28.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed
29.
Hable WE, Reddy S, Julien L (2008) The Rac1 inhibitor, NSC23766, depolarizes adhesive secretion, endomembrane cycling, and tip growth in the fucoid alga, Silvetia compressa. Planta 227:991–1000PubMedCrossRef
30.
Khan SR (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33:349–357PubMedCrossRef
31.
Ilbey YO, Ozbek E, Simsek A, Cekmen M, Somay A, Tasci AI (2009) Effects of pomegranate juice on hyperoxaluria-induced oxidative stress in the rat kidneys. Ren Fail 31:522–531PubMedCrossRef
32.
Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3–9PubMed
33.
Byer K, Khan SR (2005) Citrate provides protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium. J Urol 173:640–646PubMedCrossRef
34.
Greene EL, Farell G, Yu S, Matthews T, Kumar V, Lieske JC (2005) Renal cell adaptation to oxalate. Urol Res 33:340–348PubMedCrossRef
35.
Scheid C, Koul H, Hill WA, Luber-Narod J, Kennington L, Honeyman T, Jonassen J, Menon M (1996) Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 49:413–419PubMedCrossRef
36.
Tojo A, Onozato ML, Kobayashi N, Goto A, Matsuoka H, Fujita T (2002) Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure. Hypertension 40:834–839PubMedCrossRef
37.
Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS (2002) Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39:269–274PubMedCrossRef
38.
Geiszt M, Kopp JB, Varnai P, Leto TL (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 97:8010–8014PubMedCrossRef
39.
Babior BM, Lambeth JD, Nauseef W (2002) The neutrophil NADPH oxidase. Arch Biochem Biophys 397:342–344PubMedCrossRef
40.
Bokoch GM, Zhao T (2006) Regulation of the phagocyte NADPH oxidase by Rac GTPase. Antioxid Redox Signal 8:1533–1548PubMedCrossRef
41.
Bokoch GM, Diebold BA (2002) Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood 100:2692–2696PubMedCrossRef
42.
Gu Y, Jia B, Yang FC, D’Souza M, Harris CE, Derrow CW, Zheng Y, Williams DA (2001) Biochemical and biological characterization of a human Rac2 GTPase mutant associated with phagocytic immunodeficiency. J Biol Chem 276:15929–15938PubMedCrossRef
43.
Kim C, Dinauer MC (2001) Rac2 is an essential regulator of neutrophil nicotinamide adenine dinucleotide phosphate oxidase activation in response to specific signaling pathways. J Immunol 166:1223–1232PubMed
44.
Corbetta S, Gualdoni S, Albertinazzi C, Paris S, Croci L, Consalez GG, de Curtis I (2005) Generation and characterization of Rac3 knockout mice. Mol Cell Biol 25:5763–5776PubMedCrossRef
45.
Leung K, Nagy A, Gonzalez-Gomez I, Groffen J, Heisterkamp N, Kaartinen V (2003) Targeted expression of activated Rac3 in mammary epithelium leads to defective postlactational involution and benign mammary gland lesions. Cells Tissues Organs 175:72–83PubMedCrossRef
46.
47.
Li SM, Zeng LW, Feng L, Chen DB (2010) Rac1-dependent intracellular superoxide formation mediates vascular endothelial growth factor-induced placental angiogenesis in vitro. Endocrinology 151:5315–5325PubMedCrossRef
48.
Moldovan L, Irani K, Moldovan NI, Finkel T, Goldschmidt-Clermont PJ (1999) The actin cytoskeleton reorganization induced by Rac1 requires the production of superoxide. Antioxid Redox Signal 1:29–43PubMedCrossRef
49.
Satoh M, Ogita H, Takeshita K, Mukai Y, Kwiatkowski DJ, Liao JK (2006) Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci USA 103:7432–7437PubMedCrossRef
50.
Martin SF, Chatterjee S, Parinandi N, Alevriadou BR (2005) Rac1 inhibition protects against hypoxia/reoxygenation-induced lipid peroxidation in human vascular endothelial cells. Vascul Pharmacol 43:148–156PubMedCrossRef
51.
Yeh LH, Park YJ, Hansalia RJ, Ahmed IS, Deshpande SS, Goldschmidt-Clermont PJ, Irani K, Alevriadou BR (1999) Shear-induced tyrosine phosphorylation in endothelial cells requires Rac1-dependent production of ROS. Am J Physiol 276:C838–C847PubMed
52.
Vetter M, Chen ZJ, Chang GD, Che D, Liu S, Chang CH (2003) Cyclosporin A disrupts bradykinin signaling through superoxide. Hypertension 41:1136–1142PubMedCrossRef
53.
Mizuno T, Kaibuchi K, Ando S, Musha T, Hiraoka K, Takaishi K, Asada M, Nunoi H, Matsuda I, Takai Y (1992) Regulation of the superoxide-generating NADPH oxidase by a small GTP-binding protein and its stimulatory and inhibitory GDP/GTP exchange proteins. J Biol Chem 267:10215–10218PubMed
54.
Gregg D, Rauscher FM, Goldschmidt-Clermont PJ (2003) Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. Am J Physiol Cell Physiol 285:C723–C734PubMed
55.
Grand RJ, Owen D (1991) The biochemistry of ras p21. Biochem J 279(Pt 3):609–631PubMed
56.
57.
Kwong CH, Malech HL, Rotrosen D, Leto TL (1993) Regulation of the human neutrophil NADPH oxidase by rho-related G-proteins. Biochemistry 32:5711–5717PubMedCrossRef
58.
Heyworth PG, Knaus UG, Xu X, Uhlinger DJ, Conroy L, Bokoch GM, Curnutte JT (1993) Requirement for posttranslational processing of Rac GTP-binding proteins for activation of human neutrophil NADPH oxidase. Mol Biol Cell 4:261–269PubMed
59.
Quinn MT, Evans T, Loetterle LR, Jesaitis AJ, Bokoch GM (1993) Translocation of Rac correlates with NADPH oxidase activation. Evidence for equimolar translocation of oxidase components. J Biol Chem 268:20983–20987PubMed
60.
Abo A, Webb MR, Grogan A, Segal AW (1994) Activation of NADPH oxidase involves the dissociation of p21rac from its inhibitory GDP/GTP exchange protein (rhoGDI) followed by its translocation to the plasma membrane. Biochem J 298(Pt 3):585–591PubMed
61.
Koga H, Terasawa H, Nunoi H, Takeshige K, Inagaki F, Sumimoto H (1999) Tetratricopeptide repeat (TPR) motifs of p67(phox) participate in interaction with the small GTPase Rac and activation of the phagocyte NADPH oxidase. J Biol Chem 274:25051–25060PubMedCrossRef
62.
Lapouge K, Smith SJ, Walker PA, Gamblin SJ, Smerdon SJ, Rittinger K (2000) Structure of the TPR domain of p67phox in complex with Rac.GTP. Mol Cell 6:899–907PubMed
63.
Dang PM, Cross AR, Quinn MT, Babior BM (2002) Assembly of the neutrophil respiratory burst oxidase: a direct interaction between p67PHOX and cytochrome b558 II. Proc Natl Acad Sci USA 99:4262–4265PubMedCrossRef
64.
Bokoch GM (1995) Regulation of the phagocyte respiratory burst by small GTP-binding proteins. Trends Cell Biol 5:109–113PubMedCrossRef
65.
Wu RF, Gu Y, Xu YC, Nwariaku FE, Terada LS (2003) Vascular endothelial growth factor causes translocation of p47phox to membrane ruffles through WAVE1. J Biol Chem 278:36830–36840PubMedCrossRef
66.
Silva GB, Garvin JL (2010) Rac1 mediates NaCl-induced superoxide generation in the thick ascending limb. Am J Physiol Renal Physiol 298:F421–F425PubMedCrossRef
67.
Patil S, Bunderson M, Wilham J, Black SM (2004) Important role for Rac1 in regulating reactive oxygen species generation and pulmonary arterial smooth muscle cell growth. Am J Physiol Lung Cell Mol Physiol 287:L1314–L1322PubMedCrossRef
68.
Lemarie A, Bourdonnay E, Morzadec C, Fardel O, Vernhet L (2008) Inorganic arsenic activates reduced NADPH oxidase in human primary macrophages through a Rho kinase/p38 kinase pathway. J Immunol 180:6010–6017PubMed
69.
Zou AP, Li N, Cowley A W Jr (2001) Production and actions of superoxide in the renal medulla. Hypertension 37:547–553PubMedCrossRef
Metadata
Title
Selective Rac1 inhibition protects renal tubular epithelial cells from oxalate-induced NADPH oxidase-mediated oxidative cell injury
Authors
Vijayalakshmi Thamilselvan
Mani Menon
Sivagnanam Thamilselvan
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 4/2012
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-011-0405-7

Other articles of this Issue 4/2012

Urolithiasis 4/2012 Go to the issue

Letter to the Editor

Bladder stone due to accidentally intravesically inserted intrauterine device

Original Paper

Ureteroscopic treatment of urological calculi under sacral block anesthesia

Original Paper

Simplified estimates of ion-activity products of calcium oxalate and calcium phosphate in mouse urine

Original Paper

Can the CT planning image determine whether a kidney stone is radiopaque on a plain KUB?

Original Paper

Fragmentation without extraction in ureteral stones: outcomes of 238 cases

Original Paper

Ureteroscopic retrograde intrarenal surgery after previous open renal stone surgery: initial experience